Key facts
- Veeva's R&D Summit focused on the future of industry AI.
- The event previewed 'Falcon' and advancements in agentic biopharma operations.
- Over 2,000 leaders from companies including GSK, Roche, and Sanofi attended.
- The summit aimed to showcase strategies for streamlining and connecting operations.
Veeva's recent R&D Summit, held in Barcelona on June 4, 2026, brought together over 2,000 industry leaders to explore the future of artificial intelligence in the biopharmaceutical sector. The event highlighted advancements such as 'Falcon,' a new development aimed at enhancing agentic capabilities within biopharma operations. Representatives from major companies including AOP Health, Boehringer Ingelheim, GSK, Haleon, MSD, Novo Nordisk, Roche, Sanofi, and Sobi were present, sharing strategies focused on streamlining and connecting their operational processes. The summit underscored a collective move towards integrating advanced AI solutions to improve efficiency and connectivity across the industry.